Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer. - Piotrowska Z; Hazar-Rethinam M; Rizzo C; Nadres B; Van Seventer EE; Shahzade HA; Lennes IT; Iafrate AJ; Dias-Santagata D; Leshchiner I; Jessop NA; Hu H; et al. (JCO precision oncology, 2018)